Ambalal Sarabhai Enterprises Ltd — Important, 01-10-2025: Company Update

Ambalal Sarabhai Enterprises Limited's wholly-owned subsidiary, Synbiotics Limited, a manufacturer of fermentation-based Active Pharmaceutical Ingredients (APIs), including Amphotericin B, has successfully received its sixth consecutive approval from a USFDA inspection for GMP compliance. The API Process Inspection concluded without any regulatory actions, underscoring Synbiotics' consistent quality standards and operational excellence. This achievement is crucial for maintaining the subsidiary's strong position in the global pharmaceutical market, particularly ensuring continued access and supply for the US, a significant market for its specialized APIs.